logo
搜索
菜单

Lipophilic的搜索结果

当前1/3页
排序: 本月浏览数
3.11: Physiological Barriers 01:25 min
3.11: Physiological Barriers
9.7: Antihypertensive Drugs: Types of β-Blockers 01:28 min
9.7: Antihypertensive Drugs: Types of β-Blockers
Labeling Stem Cells with Fluorescent Dyes for non-invasive Detection with Optical Imaging 10.3791/686-v 07:42 min
Labeling Stem Cells with Fluorescent Dyes for non-invasive Detection with Optical Imaging
3.9: Passive Diffusion: Overview and Kinetics 01:17 min
3.9: Passive Diffusion: Overview and Kinetics
21.6: Types of Hormones 02:13 min
21.6: Types of Hormones
4.11: Factors Affecting Protein-Drug Binding: Drug-Related Factors 01:18 min
4.11: Factors Affecting Protein-Drug Binding: Drug-Related Factors
3.17: Factors Influencing Drug Absorption: Physicochemical Parameters 01:22 min
3.17: Factors Influencing Drug Absorption: Physicochemical Parameters
3.15: Drug Distribution: Volume of Distribution 01:25 min
3.15: Drug Distribution: Volume of Distribution
Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment 10.3791/65206-v 07:12 min
Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs 10.3791/63995-v 08:18 min
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
A New Straightforward Method for Lipophilicity (logP) Measurement using 19F NMR Spectroscopy 10.3791/58567-v 09:32 min
A New Straightforward Method for Lipophilicity (logP) Measurement using 19F NMR Spectroscopy
13.12: Pharmacokinetics in Pediatric Patients: Drug Distribution 01:17 min
13.12: Pharmacokinetics in Pediatric Patients: Drug Distribution
DiI-Labeling of DRG Neurons to Study Axonal Branching in a Whole Mount Preparation of Mouse Embryonic Spinal Cord 10.3791/3667-v 09:14 min
DiI-Labeling of DRG Neurons to Study Axonal Branching in a Whole Mount Preparation of Mouse Embryonic Spinal Cord
5.3: Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems 01:19 min
5.3: Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
4.9: Tissue-Drug Binding: Localization of Drugs and its Significance 01:24 min
4.9: Tissue-Drug Binding: Localization of Drugs and its Significance
4.8: Drug Binding to Blood Components 01:30 min
4.8: Drug Binding to Blood Components
4.4: Factors Affecting Drug Distribution: Organ Perfusion Rate 01:15 min
4.4: Factors Affecting Drug Distribution: Organ Perfusion Rate
3.19: Factors Influencing Drug Absorption: Drug Dissolution 01:27 min
3.19: Factors Influencing Drug Absorption: Drug Dissolution
6.7: Adrenergic Agonists: Mixed-Action Agents 01:28 min
6.7: Adrenergic Agonists: Mixed-Action Agents
3.20: Drug Elimination by Renal Route: Tubular Reabsorption 01:22 min
3.20: Drug Elimination by Renal Route: Tubular Reabsorption
返回顶部